Fda D.i.s.c.o. Burst Edition: Fda Approval Of Libtayo In Combination With Plati...

FDA D.I.S.C.O. Burst Edition: FDA approval of Libtayo (cemiplimab-rwlc) in combination with plati...

U.S. Food and Drug Administration

FDA D.I.S.C.O. Burst Edition: Libtayo (cemiplimab-rwlc) for first-line treatment of patients with...

U.S. Food and Drug Administration

FDA D.I.S.C.O. Burst Edition: Libtayo (cemiplimab-rwlc) for patients with locally advanced or met...

U.S. Food and Drug Administration

FDA D.I.S.C.O.: FDA approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma

U.S. Food and Drug Administration

Imdelltra: New FDA-Approved Treatment for Extensive-Stage Small Cell Lung Cancer | 2024 Update

Doses Of Videos

FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

U.S. Food and Drug Administration

FDA Approves Capmatinib for Advanced Lung Cancer

UCLA Jonsson Comprehensive Cancer Center

UCLA-led research lead to FDA approval of 4-drug combination for metastatic pancreatic cancer

Dr. Lopes on the FDA Approval of Nivolumab/Ipilimumab in NSCLC

Are there any bispecific antibodies that are FDA approved?

HealthTree University for Multiple Myeloma

FDA Approval of Tisagenlecleucel in DLBCL

FDA Approval of Second-Dosing Schedule of Nivolumab

FDA approval to targeted imaging agent Pafolacianine for use in lung cancer surgery

Medical Dialogues

Dr. Spigel on FDA Approval of Pembrolizumab/Chemo Combo in NSCLC

FDA Approvals of a Biosimilar and DTC Genetic Test, Breakthrough Designation in MZL, and More

Dr. Rischin on the FDA Approval of Cemiplimab for CSCC

Dr. Camidge on the FDA Approval of Pembrolizumab for Squamous NSCLC

Dr. Postow on FDA Approval of Cemiplimab in Metastatic Cutaneous Squamous Cell Carcinoma

Dr. Fenske Discusses Disease Progression on Ibrutinib in MCL